2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cancer‐associated fibroblasts (CAFs) consist of heterogeneous connective tissue cells and are often constituting the most abundant cell type in the tumor stroma. Radiation effects on tumor stromal components like CAFs in the context of radiation treatment is not well‐described.

          Aim

          This study explores potential changes induced by ionizing radiation (IR) on platelet‐derived growth factor (PDGF)/PDGFRs and transforming growth factor‐beta (TGF‐β)/TGFβRs signaling systems in CAFs.

          Methods and Results

          Experiments were carried out by employing primary cultures of human CAFs isolated from freshly resected non‐small cell lung carcinoma tumor tissues. CAF cultures from nine donors were treated with one high (1 × 18 Gy) or three fractionated (3 × 6 Gy) radiation doses. Alterations in expression levels of TGFβRII and PDGFRα/β induced by IR were analyzed by western blots and flow cytometry. In the presence or absence of cognate ligands, receptor activation was studied in nonirradiated and irradiated CAFs. Radiation exposure did not exert changes in expression of PDGF or TGF‐β receptors in CAFs. Additionally, IR alone was unable to trigger activation of either receptor. The radiation regimens tested did not affect PDGFRβ signaling in the presence of PDGF‐BB. In contrast, signaling via pSmad2/3 and pSmad1/5/8 appeared to be down‐regulated in irradiated CAFs after stimulation with TGF‐β, as compared with controls.

          Conclusion

          Our data demonstrate that IR by itself is insufficient to induce measurable changes in PDGF or TGF‐β receptor expression levels or to induce receptor activation in CAFs. However, in the presence of their respective ligands, exposure to radiation at certain doses appear to interfere with TGF‐β receptor signaling.

          Related collections

          Most cited references63

          • Record: found
          • Abstract: found
          • Article: not found

          TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

          Therapeutic antibodies that block the programmed death-ligand 1 (PD-L1)/programmed death-1 (PD-1) pathway can induce robust and durable responses in patients with various cancers, including metastatic urothelial cancer (mUC) 1–5 . However, these responses only occur in a subset of patients. Elucidating the determinants of response and resistance is key to improving outcomes and developing new treatment strategies. Here, we examined tumours from a large cohort of mUC patients treated with an anti–PD-L1 agent (atezolizumab) and identified major determinants of clinical outcome. Response was associated with CD8+ T-effector cell phenotype and, to an even greater extent, high neoantigen or tumour mutation burden (TMB). Lack of response was associated with a signature of transforming growth factor β (TGF-β) signalling in fibroblasts, particularly in patients with CD8+ T cells that were excluded from the tumour parenchyma and instead found in the fibroblast- and collagen-rich peritumoural stroma—a common phenotype among patients with mUC. Using a mouse model that recapitulates this immune excluded phenotype, we found that therapeutic administration of a TGF-β blocking antibody together with anti–PD-L1 reduced TGF-β signalling in stromal cells, facilitated T cell penetration into the centre of the tumour, and provoked vigorous anti-tumour immunity and tumour regression. Integration of these three independent biological features provides the best basis for understanding outcome in this setting and suggests that TGF-β shapes the tumour microenvironment to restrain anti-tumour immunity by restricting T cell infiltration.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The biology and function of fibroblasts in cancer.

            Among all cells, fibroblasts could be considered the cockroaches of the human body. They survive severe stress that is usually lethal to all other cells, and they are the only normal cell type that can be live-cultured from post-mortem and decaying tissue. Their resilient adaptation may reside in their intrinsic survival programmes and cellular plasticity. Cancer is associated with fibroblasts at all stages of disease progression, including metastasis, and they are a considerable component of the general host response to tissue damage caused by cancer cells. Cancer-associated fibroblasts (CAFs) become synthetic machines that produce many different tumour components. CAFs have a role in creating extracellular matrix (ECM) structure and metabolic and immune reprogramming of the tumour microenvironment with an impact on adaptive resistance to chemotherapy. The pleiotropic actions of CAFs on tumour cells are probably reflective of them being a heterogeneous and plastic population with context-dependent influence on cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              TGFβ signalling in context.

              The basic elements of the transforming growth factor-β (TGFβ) pathway were revealed more than a decade ago. Since then, the concept of how the TGFβ signal travels from the membrane to the nucleus has been enriched with additional findings, and its multifunctional nature and medical relevance have relentlessly come to light. However, an old mystery has endured: how does the context determine the cellular response to TGFβ? Solving this question is key to understanding TGFβ biology and its many malfunctions. Recent progress is pointing at answers.
                Bookmark

                Author and article information

                Contributors
                inigo.martinez@uit.no
                Journal
                Cancer Rep (Hoboken)
                Cancer Rep (Hoboken)
                10.1002/(ISSN)2573-8348
                CNR2
                Cancer Reports
                John Wiley and Sons Inc. (Hoboken )
                2573-8348
                15 March 2024
                March 2024
                : 7
                : 3 ( doiID: 10.1002/cnr2.v7.3 )
                : e2018
                Affiliations
                [ 1 ] Department of Community Medicine, Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
                [ 2 ] Department of Radiation Oncology University Hospital of North Norway Tromsø Norway
                [ 3 ] Department of Clinical Medicine, Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
                Author notes
                [*] [* ] Correspondence

                Inigo Martinez‐Zubiaurre, Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Postbox 6050 Langnes, Tromsø 9037, Norway.

                Email: inigo.martinez@ 123456uit.no

                Author information
                https://orcid.org/0000-0002-0919-3035
                Article
                CNR22018
                10.1002/cnr2.2018
                10941573
                38488488
                e6a7fe8b-62fe-4b61-b73b-aac881dd570f
                © 2024 The Authors. Cancer Reports published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 11 December 2023
                : 24 May 2023
                : 28 December 2023
                Page count
                Figures: 5, Tables: 4, Pages: 11, Words: 7265
                Funding
                Funded by: Universitetet i Tromsø , doi 10.13039/100007465;
                Funded by: Norwegian Regional Health Authorities
                Award ID: HNF 1337‐17 to RB
                Award ID: HNF1423‐18 to TH
                Funded by: Kreftforeningen , doi 10.13039/100008730;
                Award ID: 198164
                Funded by: Faculty of Health Sciences , doi 10.13039/501100022657;
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                March 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:15.03.2024

                cancer‐associated fibroblasts,ionizing radiation,pdgfr,radiotherapy,signaling,tgf‐β,tgfβr,tumor microenvironment,tumor stroma

                Comments

                Comment on this article